Gisele Dion Cytek Biosciences, Inc. (CTKB) insider trading activity

CTKB Quotes by TradingView

Gisele Dion is Director of Cytek Biosciences, Inc.. Currently has a direct ownership of 5,000 shares of CTKB, which is worth approximately $27,200. The most recent transaction as insider was on Jul 22, 2021, when has been sold 5,000 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $85,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $27,200

Gisele Dion Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 22 2021
BUY
Open market or private purchase
$85,000 $17.0 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

IKT
Inhibikase Therapeutics, Inc. Healthcare
GD

Gisele Dion

Director
Atlanta, GA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTKB